Highlighting a year in ANFF Materials for 2020.
Development of customised printer and training protocols for delivery of 3D Alek to Institute of Academic Surgery (IAS) at Sydney Royal Prince Alfred Hospital
Development of the 3D Genii to produce facial prosthetics from silicone materials.
Comprehensive rheological characterization to enable optimisation of bioinks was supplied for the iFix project.
Demonstrated scalability of the edge functionalised graphene production process.
Developed and deployed the only public display of printed solar in Australia
TRICEP Specific Selected Highlights for 2020
Maintaining ANFF Materials and TRICEP at the state-of-the-art in commercial additive fabrication technologies with over AU$1million invested in new hardware in 2020.
Bioinks supplied to St Vincent’s Hospital (Melbourne) to enable completion of preclinical trials for cartilage regeneration.
Development of multifunctional polymer with dual crosslinkable functionality: bivalent ions (Ca2+) and photo-crosslinkable groups to improve application performance of biopolymer for cartilage regeneration project
Delivered 10 week 3D bioprinting short course for attendees across the globe.
Launch of 3DREDI Platform for supply to global collaborators from the start of 2021.
Supply of customized printer and bioinks to enable preclinical trials with Axcelda Biopen completed.
Supply of iFix pen for preclinical trials with iFix Medical completed.
Established supply sources for alginate and hyaluronic acid.
Established sterilization and packaging protocols for selected bioinks.
Established low volume manufacturing protocols for the Sutrode.
Assistance in the covid-19 response for ISLHD by bringing local additive fabrication companies and TRICEP together to deliver face shields for use in hospitals.
Additive manufacturing expertise collaborative engagement workshop in March.
Launch of ANFF Materials and TRICEP Websites.
Comments